Provided by Tiger Trade Technology Pte. Ltd.

Heron Therapeutics

0.8588
-0.0124-1.42%
Post-market: 0.8501-0.0087-1.01%19:43 EDT
Volume:1.05M
Turnover:912.56K
Market Cap:162.31M
PE:-4.88
High:0.8953
Open:0.8800
Low:0.8543
Close:0.8712
52wk High:2.30
52wk Low:0.7362
Shares:189.00M
Float Shares:134.00M
Volume Ratio:0.55
T/O Rate:0.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1761
EPS(LYR):-0.1211
ROE:-2408.88%
ROA:-2.71%
PB:20.07
PE(LYR):-7.09

Loading ...

Heron Therapeutics Faces Tight Covenant Constraints That Threaten Liquidity and Strategic Flexibility

TIPRANKS
·
May 12

Heron Therapeutics Signals Recovery Despite Soft Q1

TIPRANKS
·
May 12

Analysts’ Opinions Are Mixed on These Healthcare Stocks: ALX Oncology Holdings (ALXO) and Heron Therapeutics (HRTX)

TIPRANKS
·
May 12

Heron Therapeutics price target lowered to $4 from $6 at H.C. Wainwright

TIPRANKS
·
May 12

Heron Therapeutics backs FY26 revenue view $173M-$183M, consensus $174.73M

TIPRANKS
·
May 12

Heron Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 11

Heron Therapeutics' Q1 revenue falls as oncology sales drop

Reuters
·
May 11

Heron Therapeutics Q1 EPS $(0.04) Misses $(0.03) Estimate, Sales $34.711M Miss $38.350M Estimate

Benzinga
·
May 11

BRIEF-Heron Therapeutics Q1 EPS USD -0.04

Reuters
·
May 11

Heron Therapeutics Inc: Reaffirmed 2026 Full-Year Guidance of $173-$183 Mln Net Revenue

THOMSON REUTERS
·
May 11

Heron Therapeutics Q1 Net Product Sales USD 34.711 Million

THOMSON REUTERS
·
May 11

Heron Therapeutics Q1 Operating Expenses USD 28.838 Million

THOMSON REUTERS
·
May 11

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

GlobeNewswire
·
May 11

Heron Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
May 08

Heron Therapeutics to report first-quarter results, host conference call and webcast

Reuters
·
Apr 28

Heron Therapeutics (HRTX): Buy Rating on Expanding Hospital Product Adoption and Attractive Risk‑Reward

TIPRANKS
·
Apr 17

Heron Therapeutics Strengthens Executive Contracts Amid Strategic Focus

TIPRANKS
·
Apr 06

Heron CEO payout rises to 200% salary plus 200% bonus in change-in-control exit

Reuters
·
Apr 06

Heron Therapeutics Signals Profitable Growth After Strong Quarter

TIPRANKS
·
Mar 06

Heron Therapeutics: Profitable Growth Outlook and Acute Care Momentum Underpin Buy Rating and $3 Target

TIPRANKS
·
Feb 27